Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...